Genes
Oligo Pools
NGS
Variant Libraries
Synthetic Controls
Antibody Discovery
IVDR Solutions
Protocol
Product Sheet
Webinar
Twist Bioscience HQ
681 Gateway Blvd
South San Francisco, CA 94080
Multi-cancer Early Detection by means of Cell-free DNA Methylation in Solid Tumors
Presented by
Dr. Smiths S. Lueong (Priv.-Doz. Dr. rer. nat.)
Senior Scientist, Bridge Institute for Experimental Tumor Therapy, West German Cancer Center, University Hospital Essen
Covered in this Webinar
Understand the biological significance of cfDNA methylation changes in the context of early carcinogenesis and tumor classification.
Explore the power of Next-Generation Sequencing (NGS)-based strategies to profile complex epigenetic signatures in liquid biopsy samples.
Learn about the current challenges and future directions for translating methylation-based assays from the lab to clinical practice.
Early and accurate cancer detection can change lives — and the future of # oncology. Join us for this webinar on demand with Dr. Smiths S. Lueong (Priv.-Doz. Dr. rer. nat.), Senior Scientist at University Hospital Essen and expert in molecular oncology, as he explores how cfDNA methylation patterns are transforming multi-cancer early detection through liquid biopsy innovations.
Don’t miss this opportunity to discover the latest breakthroughs in epigenetic biomarkers, NGS-based profiling, and clinical translation that are reshaping how we detect and treat cancer.
Share your details to Watch the Webinar
